LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 50 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,865,000 | -0.5% | 5,000,000 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $4,887,000 | -2.6% | 5,000,000 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $5,016,000 | -0.3% | 5,000,000 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $5,032,000 | +1.8% | 5,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,941,000 | +58.9% | 5,000,000 | +66.7% | 0.00% | +33.3% |
| Q1 2021 | $3,110,000 | +8.3% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,872,000 | +5.3% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,727,000 | -92.5% | 3,000,000 | -92.9% | 0.00% | -92.9% |
| Q2 2020 | $36,493,000 | -39.9% | 41,980,000 | -42.6% | 0.04% | -48.1% |
| Q1 2020 | $60,706,000 | -29.5% | 73,090,000 | -26.2% | 0.08% | +2.5% |
| Q4 2019 | $86,106,000 | +4.0% | 99,090,000 | +0.5% | 0.08% | -2.5% |
| Q3 2019 | $82,764,000 | -1.2% | 98,640,000 | +1.5% | 0.08% | +3.8% |
| Q2 2019 | $83,789,000 | – | 97,140,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 64,118,000 | $55,709,000 | 4.91% |
| SYMPHONY ASSET MANAGEMENT LLC | 9,000,000 | $7,790,000 | 1.72% |
| CANYON CAPITAL ADVISORS LLC | 65,000,000 | $56,160,000 | 1.31% |
| CAMDEN ASSET MANAGEMENT L P /CA | 44,450,000 | $38,362,000 | 1.24% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 60,954,000 | $52,832,000 | 1.02% |
| Context Capital Management, LLC | 2,350,000 | $2,028,000 | 1.02% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,160,000 | $3,622,000 | 0.47% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,418,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 23,903,000 | $20,688,000 | 0.39% |
| WOLVERINE ASSET MANAGEMENT LLC | 36,633,000 | $31,784,000 | 0.37% |